ZEB1 and neoplasm: In the early stages of MBC, EMT-TFs, like TWIST1, ZEB1/2, and SLUG, repress E-cadherin and β-catenin expression; promote EMT, cell motility and invasiveness; and permit the intravasation of tumor cells [15–18].